Form 4: Cryoport CEO Jerrell Shelton Exercises Stock Options, Boosts Direct Ownership
Insider Transaction Report
Cryoport, Inc. President and CEO Jerrell Shelton exercised 50,000 stock options at $5 per share, increasing his direct beneficial ownership of common stock to 812,419 shares.
Summary
- Jerrell Shelton, President and CEO of Cryoport, Inc. (CYRX), reported a transaction on June 2, 2025.
- The transaction involved the exercise of 50,000 stock options at an exercise price of $5.00 per share.
- Following this transaction, Mr. Shelton's direct beneficial ownership of Cryoport common stock increased to 812,419 shares.
- The exercised options were part of a grant where 1/48th vested on the 19th of each month for forty-eight months, commencing August 19, 2015.
- After the exercise, Mr. Shelton still beneficially owns 606,064 derivative securities (stock options).
Sentiment
Score: 7
Explanation: The exercise of stock options by the CEO, increasing his direct ownership, generally signals confidence in the company's future performance, which is a positive indicator for investors.
Positives
- Increased direct beneficial ownership by a key executive (President and CEO), signaling confidence in the company's future.
- The exercise of options at a fixed price allows the executive to convert potential value into actual shares, aligning their interests further with shareholders.
Negatives
- The transaction is an exercise of previously granted options, not an open market purchase, which might be viewed differently by some investors.
Industry Context
This insider transaction by Cryoport's CEO, Jerrell Shelton, is a common occurrence in the biotechnology and life sciences logistics industry, where executive compensation often includes stock options. Such exercises can be interpreted as a sign of continued executive confidence in the company's long-term prospects within its specialized market.
Stakeholder Impact
- Shareholders may view the CEO's increased direct ownership as a positive signal of management's alignment with shareholder interests and belief in the company's future value.
Key Dates
| Date | Description |
|---|---|
| 08/19/2015 | Start date for vesting of stock options (1/48th vested monthly for 48 months). |
| 06/02/2025 | Date of transaction (exercise of stock options). |
| 06/03/2025 | Date the Form 4 was signed by Jerrell Shelton. |
| 11/20/2025 | Expiration date of the derivative securities (stock options). |
Keywords
Cryoport, CYRX, Jerrell Shelton, Stock Options, Insider Transaction, Form 4, Beneficial Ownership, CEO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.